Terms: = Colorectal cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2
1312 results:
1. Genomic Alterations and Clinical Characterization in Chinese Patients with Metastatic colorectal cancer.
Zhang XH; Zhou JQ; Wei Q; Li J; Xu T; Bai CM; Zhou JF; Wang XC
Discov Med; 2024 Jul; 36(186):1477-1485. PubMed ID: 39054718
[TBL] [Abstract] [Full Text] [Related]
2. [Clinicopathological analysis of gastric adenocarcinoma with elevated serum alpha-fetoprotein and enteroblastic differentiation].
Zan LK; Shen LL; Zhang X; Gao N; Tian BG; Geng XX; Peng X; Li JW; Bu P; Zhao GH
Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):686-695. PubMed ID: 39034804
[No Abstract] [Full Text] [Related]
3. [Clinical curative effect of enteroscopic stent implantation combined with laparoscopy in patients with colorectal cancer and intestinal obstruction].
Gu JB; Yang H; Bao XB; Ma Z; Gu ZY
Zhonghua Yi Xue Za Zhi; 2024 Jul; 104(28):2637-2641. PubMed ID: 39019821
[TBL] [Abstract] [Full Text] [Related]
4. Current and Emerging Treatment Paradigms in colorectal cancer: Integrating Hallmarks of cancer.
Salva de Torres C; Baraibar I; Saoudi González N; Ros J; Salva F; Rodríguez-Castells M; Alcaraz A; García A; Tabernero J; Élez E
Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000083
[TBL] [Abstract] [Full Text] [Related]
5. [Pharmacological properties and clinical development overview of pertuzumab (genetical recombination), trastuzumab (genetical recombination) and vorhyaluronidase alfa (genetical recombination) (PHESGO
Sakaeda M; Kotani N; Yoneya T; Zheng Y; Habara Y
Nihon Yakurigaku Zasshi; 2024; 159(4):241-253. PubMed ID: 38945908
[TBL] [Abstract] [Full Text] [Related]
6. Progress in clinical diagnosis and treatment of colorectal cancer with rare genetic variants.
Chen S; Gu J; Wu K; Zhao X; Lu Y
Cancer Biol Med; 2024 Jun; 21(6):473-83. PubMed ID: 38940668
[TBL] [Abstract] [Full Text] [Related]
7. Immunohistochemical Expression of Human Epidermal Growth Factor Receptor 2 and Ki67 in Apocrine Gland Anal Sac Adenocarcinoma.
Paiva F; Santos J; Carra G; Sueiro F; Jark P; Nardi A
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928157
[TBL] [Abstract] [Full Text] [Related]
8. her2-neu Expression and Survival in colorectal cancer in the South of Egypt; Immunohistochemistry and Genetic Study.
El-Deek HEM; Hafez MMA; Sotouhy TMM; Mosad Zaki E; Eltyb HA; Kamal FMM
Asian Pac J Cancer Prev; 2024 Jun; 25(6):2023-2032. PubMed ID: 38918664
[TBL] [Abstract] [Full Text] [Related]
9. Temporal and spatial heterogeneity of her2 status in metastatic colorectal cancer.
D'Angelo F; Monnien F; Overs A; Pem I; Dor F; Abad M; Felix S; Selmani Z; Lakkis Z; Borg C; Doussot A; Bibeau F; Molimard C
Diagn Pathol; 2024 Jun; 19(1):88. PubMed ID: 38909265
[TBL] [Abstract] [Full Text] [Related]
10. Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer.
Chen SH; Tse KP; Lu YJ; Chen SJ; Tian YF; Tan KT; Li CF
Cancer Med; 2024 Jun; 13(12):e7384. PubMed ID: 38895905
[TBL] [Abstract] [Full Text] [Related]
11. Treatment of patients with carcinomas in advanced stages with 5-fluorouracil, folinic acid and pyridoxine in tandem.
Machover D; Almohamad W; Castagné V; Desterke C; Gomez L; Goldschmidt E
Sci Rep; 2024 May; 14(1):12054. PubMed ID: 38802419
[TBL] [Abstract] [Full Text] [Related]
12. Plasma ctDNA enhances the tissue-based detection of oncodriver mutations in colorectal cancer.
Wang W; Huang Y; Kong J; Lu L; Liao Q; Zhu J; Wang T; Yan L; Dai M; Chen Z; You J
Clin Transl Oncol; 2024 Aug; 26(8):1976-1987. PubMed ID: 38777950
[TBL] [Abstract] [Full Text] [Related]
13. Epidermal growth factor receptor antagonists in colorectal cancer: emerging strategies for precision therapy.
González NS; Marchese PV; Baraibar I; Ros J; Salvà F; Rodríguez M; Salvà C; Vaghi C; Alcaraz A; García A; Tabernero J; Élez E
Expert Opin Investig Drugs; 2024 Jun; 33(6):613-625. PubMed ID: 38775361
[TBL] [Abstract] [Full Text] [Related]
14. RAS/RAF mutations and microsatellite instability status in primary colorectal cancers according to her2 amplification.
Lee SM; Oh H
Sci Rep; 2024 May; 14(1):11432. PubMed ID: 38763942
[TBL] [Abstract] [Full Text] [Related]
15. Pembrolizumab Plus mFOLFOX7 or FOLFIRI for Microsatellite Stable/Mismatch Repair-Proficient Metastatic colorectal cancer: KEYNOTE-651 Cohorts B and D.
Kim R; Tehfe M; Kavan P; Chaves J; Kortmansky JS; Chen EX; Lieu CH; Wong L; Fakih M; Spencer K; Zhao Q; Predoiu R; Li C; Leconte P; Adelberg D; Chiorean EG
Clin Colorectal Cancer; 2024 Jun; 23(2):118-127.e6. PubMed ID: 38762348
[TBL] [Abstract] [Full Text] [Related]
16. Extra-appendiceal mucinous neoplasms: A tumour with clinicopathologic similarities to low- and high-grade appendiceal counterpart.
Chen F; Harvey SE; Young ED; Liang TZ; Larman T; Voltaggio L
Hum Pathol; 2024 Jun; 148():23-31. PubMed ID: 38677555
[TBL] [Abstract] [Full Text] [Related]
17. Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy.
Montagna G; Mrdutt MM; Sun SX; Hlavin C; Diego EJ; Wong SM; Barrio AV; van den Bruele AB; Cabioglu N; Sevilimedu V; Rosenberger LH; Hwang ES; Ingham A; Papassotiropoulos B; Nguyen-Sträuli BD; Kurzeder C; Aybar DD; Vorburger D; Matlac DM; Ostapenko E; Riedel F; Fitzal F; Meani F; Fick F; Sagasser J; Heil J; Karanlik H; Dedes KJ; Romics L; Banys-Paluchowski M; Muslumanoglu M; Perez MDRC; Díaz MC; Heidinger M; Fehr MK; Reinisch M; Tukenmez M; Maggi N; Rocco N; Ditsch N; Gentilini OD; Paulinelli RR; Zarhi SS; Kuemmel S; Bruzas S; di Lascio S; Parissenti TK; Hoskin TL; Güth U; Ovalle V; Tausch C; Kuerer HM; Caudle AS; Boileau JF; Boughey JC; Kühn T; Morrow M; Weber WP
JAMA Oncol; 2024 Jun; 10(6):793-798. PubMed ID: 38662396
[TBL] [Abstract] [Full Text] [Related]
18. Biomarker-oriented chemo-immunotherapy for advanced gastric cancer.
Kono K; Nakajima S; Mimura K
Int J Clin Oncol; 2024 Jul; 29(7):865-872. PubMed ID: 38647874
[TBL] [Abstract] [Full Text] [Related]
19. Genomic ancestry and cancer among Latin Americans.
Ruíz-Patiño A; Rojas L; Zuluaga J; Arrieta O; Corrales L; Martín C; Franco S; Raez L; Rolfo C; Sánchez N; Cardona AF
Clin Transl Oncol; 2024 Aug; 26(8):1856-1871. PubMed ID: 38581481
[TBL] [Abstract] [Full Text] [Related]
20. Telangiectasias induced by combination tucatinib and ado-trastuzumab emtansine in a patient with metastatic breast cancer.
Rodriguez GF; Shah A; Maderal AD
Breast Dis; 2024; 43(1):61-64. PubMed ID: 38578876
[TBL] [Abstract] [Full Text] [Related]
[Next]
